Standout Papers

Impact of medical and demographic factors on long-term quality of life and body image of breast... 2003 2026 2010 2018 161
  1. Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients (2003)
    Kristin Härtl, Wolfgang Janni et al. Annals of Oncology

Citation Impact

Citing Papers

Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition
2013 StandoutScience
Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular Carcinoma
2014 Standout
Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases
2004 Standout
Isolation and Molecular Profiling of Bone Marrow Micrometastases Identifies TWIST1 as a Marker of Early Tumor Relapse in Breast Cancer Patients
2007
Metastasis: from dissemination to organ-specific colonization
2009 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
2011 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Breast cancer
2019 Standout
Manual for guided home exercises for osteoarthritis of the knee
2010
Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients
2003
Comparison of HER2 status between primary tumor and disseminated tumor cells in␣primary breast cancer patients
2006
Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment
2008
Dissecting the metastatic cascade
2004
Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal Cancer
2005
Correlates of fear of cancer recurrence in women with ductal carcinoma in situ and early invasive breast cancer
2011
Concerns of former breast cancer patients about disease recurrence: a validation and prevalence study
2008
Cancer micrometastasis and tumour dormancy
2008
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Breast cancer
2016 Standout
Cancer to bone: a fatal attraction
2011 Standout
EMT and Dissemination Precede Pancreatic Tumor Formation
2012 Standout
Disseminated Tumor Cells in Bone Marrow and Circulating Tumor Cells in Blood of Breast Cancer Patients: Current State of Detection and Characterization
2008
Cancer Metastasis: Building a Framework
2006 Standout
Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial
2006 Standout
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
2013 Standout
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
The molecular biology of head and neck cancer
2010 Standout
Current and future perspectives of liquid biopsies in genomics-driven oncology
2018 Standout
Significance, detection and markers of disseminated breast cancer cells
2006
A family‐based model to predict fear of recurrence for cancer survivors and their caregivers
2006
A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation
2006
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Dance and Movement Program Improves Quality-of-Life Measures in Breast Cancer Survivors
2005
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2010 Standout
Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel
2007
Circulating tumour cells in cancer patients: challenges and perspectives
2010
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Apoptosis of circulating tumor cells in prostate cancer patients
2004
Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials
2015
Fear of cancer recurrence: specific profiles and nature of intrusive thoughts
2010
Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study
2010
Molecular requirements for epithelial–mesenchymal transition during tumor progression
2005 Standout
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Role of bisphosphonates in postmenopausal women with breast cancer
2013
Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment
2011
Cancer micrometastases
2009
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
2013 Standout
Emerging Biological Principles of Metastasis
2017 Standout
Cancer treatment and survivorship statistics, 2012
2012 Standout
EMT: 2016
2016 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis
2013 Standout
Microenvironmental regulation of metastasis
2008 Standout
Dormancy in breast cancer
2012
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Direct and indirect anticancer activity of bisphosphonates: A brief review of published literature
2011
Genomic analysis of single cytokeratin-positive cells from bone marrow reveals early mutational events in breast cancer
2005
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Detection, clinical relevance and specific biological properties of disseminating tumour cells
2008
The secret ally: immunostimulation by anticancer drugs
2012
Metastatic colonization by circulating tumour cells
2016 StandoutNature
Effects of Bone-Targeted Agents on Cancer Progression and Mortality
2012
Cancer-related inflammation
2008 StandoutNature
Review: Biological relevance of disseminated tumor cells in cancer patients
2008
Breast cancer metastasis: markers and models
2005 Standout
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
Detection of cytokeratin-positive cells in the bone marrow of breast cancer patients undergoing adjuvant therapy
2005
Reliable and Sensitive Identification of Occult Tumor Cells Using the Improved Rare Event Imaging System
2004
Detection of Isolated Tumor Cells in Bone Marrow Is an Independent Prognostic Factor in Breast Cancer
2003
The Connection Between Art, Healing, and Public Health: A Review of Current Literature
2009 Standout
American College of Sports Medicine Roundtable on Exercise Guidelines for Cancer Survivors
2010 Standout
Development and Validation of Disease-Specific Measures for Choroidal Melanoma
2003
A Perspective on Cancer Cell Metastasis
2011 StandoutScience
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
2005 Standout
Radioactive Iodine Therapy Decreases Recurrence in Thyroid Papillary Microcarcinoma
2012
Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells
2016 StandoutNobel
Fear of cancer recurrence: a systematic literature review of self‐report measures
2011
Disseminated Tumor Cells of Breast Cancer Patients: A Strong Prognostic Factor for Distant and Local Relapse
2008
Effect of Endocrine Therapies on Bone in Breast Cancer Patients
2010
Multigene Reverse Transcription-PCR Profiling of Circulating Tumor Cells in Hormone-Refractory Prostate Cancer
2004
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Circulating Tumor Cell Detection Predicts Early Metastatic Relapse After Neoadjuvant Chemotherapy in Large Operable and Locally Advanced Breast Cancer in a Phase II Randomized Trial
2008
Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer
2015
Alemtuzumab for patients with chronic lymphocytic leukaemia
2012
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Changes in Cytoskeletal Protein Composition Indicative of an Epithelial-Mesenchymal Transition in Human Micrometastatic and Primary Breast Carcinoma Cells
2005
Factors reported to influence fear of recurrence in cancer patients: a systematic review
2012
Isolated Tumor Cells in Bone Marrow Three Years after Diagnosis in Disease-Free Breast Cancer Patients Predict Unfavorable Clinical Outcome1
2004
Circulating Tumor Cells and Bone Marrow Micrometastasis
2008
Changes in Neurologic Function Tests May Predict Neurotoxicity Caused by Ixabepilone
2006
Metastatic Behavior of Breast Cancer Subtypes
2010 Standout
Disseminated Tumor Cells in Prostate Cancer Patients after Radical Prostatectomy and without Evidence of Disease Predicts Biochemical Recurrence
2009
The epithelial–mesenchymal transition: new insights in signaling, development, and disease
2006 Standout
Immunogenic Cell Death in Cancer Therapy
2012 Standout

Works of B. Strobl being referenced

Zoledronsäure bei persistierenden isolierten Tumorzellen im Knochenmark bei Mammakarzinom
2008
Patients with Recurrent Breast Cancer: Does the Primary Axillary Lymph node Status Predict more Aggressive Tumor Progression?
2003
The persistence of isolated tumor cells in bone marrow from patients with breast carcinoma predicts an increased risk for recurrence
2005
Impact of medical and demographic factors on long-term quality of life and body image of breast cancer patients
2003 Standout
The fate and prognostic value of occult metastatic cells in the bone marrow of patients with breast carcinoma between primary treatment and recurrence
2001
Quality of Life Influenced by Primary Surgical Treatment for Stage I-III Breast Cancer?Long-Term Follow-Up of a Matched-Pair Analysis
2001
Patterns of disease recurrence influenced by hematogenous tumor cell dissemination in patients with cervical carcinoma of the uterus
2003
Effect of zoledronate on persisting isolated tumor cells (ITC) in the bone marrow (BM) of patients without recurrence of early breast cancer
2004
Effect of zoledronate on persisting isolated tumour cells in patients with early breast cancer.
2010
Association of persistence of isolated tumor cells (ITC) in bone marrow (BM) of breast cancer patients with risk for relapse
2004
Rankless by CCL
2026